As well as its needed effects, iodixanol (the active ingredient contained in Visipaque) may cause unwanted side effects that require medical attention. 
Some iodixanol side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
Serious reactions as well as fatalities are only seen on very rare occasions.  Serious adverse reactions may include acute/chronic renal failure, anaphylactic or anaphylactoid shock, hypersensitivity reaction followed by cardiac reactions (Kounis' syndrome), cardiac or cardio-respiratory arrest and myocardial infarction.
Very common (10% or more): Vaginal hemorrhage (intrathecal)Uncommon (0.1% to 1%): Hematuria
Common (1% to 10%): Angina pectoris, chest painUncommon (0.1% to 1%): Arrhythmias, cardiac failure, conduction abnormalities, hypotension, myocardial infarction, flushing, peripheral ischemia.Rare (0.01% to 0.1%): HypotensionVery rare (less than 0.01%): Hypertension, ischemiaFrequency not reported: Ventricular hypokinesia, myocardial ischemia, arterial spasm, thrombosis, thrombophlebitis, thrombocytopenia, cardiorespiratory arrest, spasm of coronary arteries, shock
Common (1% to 10%): Nonurticarial rash, erythema, pruritus, rash, urticariaUncommon (0.1% to 1%): Hematoma, increased sweatingVery rare (less than 0.01%): AngioedemaFrequency not reported: Severe pustular or bullous skin reactions, Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug rash with eosinophilia and systemic symptoms, drug eruption, dermatitis allergic, skin exfoliation
Common (1% to 10%): NauseaUncommon (0.1% to 1%): Diarrhea, vomiting, dyspepsiaVery rare (less than 0.01%): Abdominal pain, abdominal discomfortFrequency not reported: Acute pancreatitis, pancreatitis aggravated, salivary gland enlargement
Common (1% to 10%): Injection site pain
Common (1% to 10%): Headache, migraine, paresthesiaUncommon (0.1% to 1%): Nervousness, dizziness, sensory disturbance, syncope, parosmia, cerebral vascular disorder, convulsions, hypoesthesia, stuporVery rare (less than 0.01%): Cerebrovascular accident, amnesiaFrequency not reported: Disturbances in consciousness, coma, motor dysfunction, transient contrast induced encephalopathy (including hallucination), tremorPostmarketing reports: Dyskinesia
Common (1% to 10%): ScotomaUncommon (0.1% to 1%): Abnormal visionFrequency not reported: Transient blindness
Common (1% to 10%): VertigoUncommon (0.1% to 1%): Edema, fatigue, malaise, tinnitus, feeling hotRare (0.01% to 0.1%): Pain, pyrexia, shivering (chills), administration site reactions includingextravasationVery rare (less than 0.01%): Feeling cold, asthenic conditionsFrequency not reported: Iodism
Hypersensitivity reactions usually present as respiratory or cutaneous symptoms like dyspnea, rash, erythema, urticaria, pruritus, skin reaction, angioneurotic edema, hypotension, fever, laryngeal edema, bronchospasm or pulmonary edema.  They may appear either immediately after the injection or up to a few days later.Hypersensitivity reactions may occur irrespectively of the dose and mode of administration and mild symptoms may represent the first signs of a serious anaphylactoid reaction/shock.
Uncommon (0.1% to 1%): Pharyngeal edemaFrequency not reported: Anaphylactoid reaction, anaphylactoid shock
Uncommon (0.1% to 1%): Agitation, anxiety, insomnia, confusion
Uncommon (0.1% to 1%): Abnormal renal function, acute renal failure
Uncommon (0.1% to 1%): Asthma, bronchitis, dyspnea, pulmonary edema, rhinitisRare (less than 0.1%): CoughFrequency not reported: Non-cardiogenic pulmonary edema, respiratory arrest, respiratory failurePostmarketing reports: Pulmonary embolism, respiratory depression
Rare (less than 0.1%): Back painFrequency not reported: ArthralgiaPostmarketing reports: Polymyalgia rheumatica
Postmarketing reports: Hemorrhage
Postmarketing reports: Hypoglycemia
It is possible that some side effects of Visipaque may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
Arm, back, or jaw pain
chest pain or discomfort
chest tightness or heaviness
fainting
fast or irregular heartbeat
nausea
shortness of breath
sweating
Agitation
blurred vision
chest pain or discomfort
coma
confusion
cough
decreased urine output
depression
difficulty breathing
dilated neck veins
dizziness
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
extreme fatigue
fainting
feeling of warmth
headache
hostility
irregular breathing
irritability
lethargy
muscle twitching
noisy breathing
pain or discomfort in the arms, jaw, back, or neck
rapid weight gain
redness of the face, neck, arms, and occasionally, upper chest
seizures
severe or sudden headache
stupor
sudden loss of coordination
sudden slurring of speech
swelling of the face, ankles, or hands
swelling of the fingers, feet, or lower legs
vomiting
weight gain
Bad, unusual, or unpleasant (after) taste
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
change in taste
diarrhea
dizziness or lightheadedness
feeling of constant movement of self or surroundings
itching or skin rash
sensation of spinning
Acid or sour stomach
anxiety
back pain
belching
continuing ringing or buzzing or other unexplained noise in the ears
decreased awareness or responsiveness
dry mouth
general feeling of discomfort or illness
hearing loss
heartburn
hives or welts
hyperventilation
indigestion
redness of the skin
restlessness
severe sleepiness
shaking
stomach discomfort, upset, or pain
transient, mild, pleasant aromatic odor
trouble sleeping